| Literature DB >> 29233172 |
Tiago Correia1, Graça Carapinheiro2, Helena Carvalho2, José Manuel Silva3, Gilles Dussault4.
Abstract
BACKGROUND: The European Union member countries reacted differently to the 2008 economic and financial crisis. However, few countries have monitored the outcomes of their policy responses, and there is therefore little evidence as to whether or not savings undermined the performance of health systems. We discuss the situation in Portugal, where a financial adjustment program was implemented between 2011 and 2014, and explore the views of health workers on the effects of austerity measures on quality of care delivery.Entities:
Keywords: Adjustment programs; Austerity measures; Economic crisis; Portugal; Quality of care; Trust
Mesh:
Year: 2017 PMID: 29233172 PMCID: PMC5727927 DOI: 10.1186/s12960-017-0256-6
Source DB: PubMed Journal: Hum Resour Health ISSN: 1478-4491
Implementation of the MoU in Portugal 2011–2014
| Policy outcome | ||||||
|---|---|---|---|---|---|---|
| Accomplished | Partially accomplished | Not accomplished | Withdrawn/omitted | |||
| Cost sharing | Review and increase patient fees | x | ||||
| Reduction of exemption categories | x | |||||
| Increase inflation-indexed fees | x | |||||
| Cut tax allowances for healthcare, including private insurance | x | |||||
| Reduce the cost of health benefits schemes for public servants | x | |||||
| Reduce costs for patient transportation | x | |||||
| Regulation of the drug market | Control retail price | x | ||||
| Move the responsibility of pricing to the Ministry of Health | x | |||||
| Revise the international reference-pricing system | x | |||||
| Monitor expenditure monthly and limit public spending | x | |||||
| Remove barriers to generic medicines | x | |||||
| Change the calculation of pharmacies’ profit margin | x | |||||
| Gradually increase the share of generic medicines | x | |||||
| Implement existing legislation on the regulation of pharmacies | x | |||||
| Speed up the reimbursement of generics | x | |||||
| Introduce a contribution paid by pharmacies | x | |||||
| Control of doctors’ prescription | Make electronic prescription of medicines and diagnostic tests covered by public reimbursement fully compulsory for physicians (public and private sectors) | x | ||||
| Encourage physicians to prescribe generic medicines and less costly branded products (public and private sectors) | x | |||||
| Introduce international prescription guidelines for drugs, exams and treatment | x | |||||
| Improve monitoring of prescription of medicines and diagnostic services and impose systematic assessments by each doctor of quantity and cost. Introduce sanctions and penalties | x | |||||
| Control of operating costs and performance in the NHS | Legislative and administrative framework for a centralized procurement system for the purchase of medical goods | x | ||||
| Change in the existing accounting framework in hospitals SOEs to that of private companies and other SOEs | x | |||||
| Concentration and rationalization of non-hospital care provision | x | |||||
| Concentration and rationalization of the hospital network | x | |||||
| Continued publication of clinical guidelines and introduction of an auditing system | x | |||||
| Benchmarking of hospital performance | x | |||||
| Interoperability of IT systems in hospitals | x | |||||
| Finalization and regular updates of uniform coding system for medical supplies | x | |||||
| Implement the centralized purchasing of medical goods using the uniform coding system | x | |||||
| Clearing of existing arrears in the hospital sector and prevention of accumulation of new arrears | x | |||||
| Completion of patient electronic medical records | x | |||||
| Public-private relationship | Increase in competition between private providers and reduction in NHS payment of exams and treatments | x | ||||
| Centralized monitoring of public-private partnership contracts | x | |||||
| Regular revision of fees paid by the NHS for exams and treatment by private providers | x | |||||
| Assessment of compliance with European competition rules for the provision of services in the private healthcare sector | x | |||||
| Access to healthcare | Reinforce primary health care | Increase the number of patients per primary care unit/family doctor | x | |||
| Increase the number of primary care units using salary and performance-related payments | x | |||||
| Separate HR from hospitals and reconsider the role of nurses and other professionals | x | |||||
| Review geographical distribution of GPs | x | |||||
| Move hospital outpatient services to primary care units | x | |||||
| Workforce | Update working time, increase mobility, adopt flexible time arrangements and review payment mechanisms | x | ||||
| Conduct an annual inventory of doctors | x | |||||
| Make human resource allocation plans | x | |||||
| Increase mobility of healthcare staff within and between regions | x | |||||
| Ensure transparent selection of the chairs and members of hospital boards | x | |||||
Legend: Own elaboration from [26, 27]
Fig. 1Analytical model
Descriptive statistics
| Analyses variables and categories |
| % | |||
|---|---|---|---|---|---|
| Independent variable | Sector of activity | Exclusive in public | 1209 | 58.6 | |
| Exclusive in private | 854 | 41.4 | |||
| Total | 2063 | 100.0 | |||
| Exclusive in public | Primary healthcare | 509 | 42.1 | ||
| Public hospitals | 634 | 52.4 | |||
| Non answer | 66 | 5.5 | |||
| Total | 1209 | 100.0 | |||
| Exclusive in private | Small-size offices | 274 | 32.1 | ||
| Clinics | 230 | 26.9 | |||
| Hospital | 79 | 9.3 | |||
| Non answer | 271 | 31.7 | |||
| Total | 854 | 100.0 | |||
| Moderator variables | Years of practice | Up to 12 years | 644 | 31.2 | |
| 13–25 years | 473 | 22.9 | |||
| 26–39 years | 520 | 25.2 | |||
| Over 40 years | 426 | 20.0 | |||
| Total | 2063 | 100.0 | |||
| Medical specialty | Anesthesiology | 59 | 2.9 | ||
| Cardiology | 28 | 1.4 | |||
| Dermatology | 17 | .8 | |||
| Gastroenterology | 23 | 1.1 | |||
| General practice/family medicine | 498 | 24.1 | |||
| General surgery | 110 | 5.3 | |||
| Internal medicine | 132 | 6.4 | |||
| Neurology | 16 | .8 | |||
| Obstetrics and gynecology | 78 | 3.8 | |||
| Oncology | 38 | 1.8 | |||
| Ophthalmology | 41 | 2.0 | |||
| Orthopedics | 49 | 2.4 | |||
| Other surgical specialties | 54 | 2.6 | |||
| Otorhinolaryngology | 29 | 1.4 | |||
| Pediatrics | 109 | 5.3 | |||
| Physical medicine and rehabilitation | 26 | 1.3 | |||
| Psychiatry | 64 | 3.1 | |||
| Public Health | 28 | 1.4 | |||
| Pulmonology | 31 | 1.5 | |||
| Radiology | 36 | 1.7 | |||
| Stomatology | 30 | 1.5 | |||
| Non answer | 567 | 27.5 | |||
| Total | 2063 | 100.0 | |||
| Dependent variables—quality of care | DV1 | No | 1465 | 82.7 | |
| Yes | 307 | 17.3 | |||
| Total | 1772 | 100.0 | |||
| DV2 | No | 639 | 35.1 | ||
| Yes | 1184 | 64.9 | |||
| Total | 1823 | 100.0 | |||
| DV3 | No | 1149 | 69.4 | ||
| Yes | 506 | 30.6 | |||
| Total | 1655 | 100.0 | |||
| DV4 | No | 1384 | 76.2 | ||
| Yes | 432 | 23.8 | |||
| Total | 1816 | 100.0 | |||
| DV5 | No | 1819 | 84.4 | ||
| Yes | 336 | 15.6 | |||
| Total | 2155 | 100.0 | |||
| DV6 | No | 747 | 51.1 | ||
| Yes | 716 | 48.9 | |||
| Total | 1463 | 100.0 | |||
Notes: (1) Sums of subject numbers for the dependent variables are not always equal because of missing data; percentages are based on number of subjects for whom data were available; (2) DV1—refusal of innovative treatments; DV2—regular shortage of work supplies; DV3—shortage of drugs; DV4—pressure to choose less-expensive treatments; DV5—pressure not to prescribe specific drugs; DV6—inferior medical training
Comparisons of quality of care between groups (t-test and one-way ANOVA)
| Sector of activity | DV1 | DV2 | DV3 | DV4 | DV5 | DV6 | |
|---|---|---|---|---|---|---|---|
| Meana | Mean | Mean | Mean | Mean | Mean | ||
| 1st step | |||||||
| Public | 0.153 | 0.731 | 0.300 | 0.262 | 0.200 | 0.435 | |
| Private | 0.134 | 0.228 | 0.110 | 0.158 | 0.058 | 0.571 | |
| Model test |
|
|
|
|
|
| |
| 2nd step | |||||||
| Public | Primary healthcare | 0.065 | 0.847 | 0.091 | 0.351 | 0.267 | 0.385 |
| Public hospitals | 0.234 | 0.637 | 0.437 | 0.201 | 0.143 | 0.471 | |
| Model test |
|
|
|
|
|
| |
| Private | Small-size offices | 0.286 | 0.125 | 0.100 | 0.161 | 0.056 | 0.636 |
| Clinics | 0.074 | 0.333 | 0.129 | 0.239 | 0.061 | 0.308 | |
| Hospital | 0.167 | 0.188 | 0.133 | 0.194 | 0.100 | 0.750 | |
| Model test |
|
|
|
|
|
| |
aMean = proportion of answer “yes”
*p < .05; **p < .01; ***p < .001
Multivariate logistic regression model with the moderator effect of years of practice on quality of care
| DV1 | DV2 | DV3 | DV4 | DV5 | DV6 | |
|---|---|---|---|---|---|---|
| Exclusive in publica | 1.556 | 1.160* | − 0.104 | − 0.115 | − 0.814 | 0.571 |
| (0.857) | (0.580) | (0.714) | (0.640) | (0.710) | (0.692) | |
| Years of practice (exclusive in private) | 0.002 | − 0.003** | − 0.005** | − 0.002 | − 0.006** | 0.001 |
| (0.002) | (0.001) | (0.002) | (0.002) | (0.002) | (0.002) | |
| Exclusive in public * Years of practiceb | − 0.005* | 0.002 | 0.002 | 0.002 | 0.005** | − 0.004* |
| (0.002) | 0.001 | (0.002) | (0.002) | (0.002) | (0.002) | |
| Constant | − 2.742** | 0.212 | − 0.229 | − 0.775 | − 0.522 | 0.172 |
| (0.843) | (0.563) | (0.703) | (0.626) | (0.694) | (0.645) | |
| Model LL = | 18.316*** | 186.426*** | 57.636*** | 13.628** | 52.207*** | 24.265*** |
| Post hoc tests | ||||||
| Years of practice (exclusive in public) | − 0.003*** | − 0.002** | − 0.003*** | − 0.002** | − 0.002 | 0.000 |
| (0.001) | (0.001) | (0.002) | (0.001) | (0.001) | (0.002) |
Non-standardized coefficients and standard errors (in brackets) are reported
aExclusive private (baseline)
bInteraction effect
*p < .05; **p < .01; ***p < .001
Fig. 2Interaction between sector and years of practice in refusal of innovative treatments
Fig. 3Interaction between sector and years of practice in pressure not to prescribe certain drugs
Fig. 4Interaction between sector and years of practice in deterioration in medical training
GLM Univariate Analysis with the moderator effect on the relationship between medical specialty and quality of care
| DV1 | DV2 | DV3 | DV4 | DV5 | DV6 | |
|---|---|---|---|---|---|---|
| Sector |
|
|
|
|
|
|
| Medical specialty |
|
|
|
|
|
|
| Interaction between sector and medical specialty |
|
|
|
|
|
|
GLM General Linear Model
*p < .05; **p < .01; ***p < .001
Fig. 5Interaction between sector and medical specialty in refusal of innovative treatments
Fig. 6Interaction between sector activity and medical specialty on shortage of drugs